BioForesight.com - San Diego antibodies research company
Title
BioForesight
Description
"BioForesight" combines the experience and expertise of David Palella of BioScience Ventures, Inc. based in San Diego, California, with a network of associates from across the globe.
BioForesight comprises the most active, knowledgeable and visible team of business development and corporate partnering experts in the areas of therapeutic antibodies, proteomics, pharmaco-proteomics, genomics and chemo-genomics, as applied to therapeutic product development in oncology, infectious disease, CNS disorders, and the molecular basis of aging. We are the originators and co-chairs of such first-in-class conferences as Strategic Research Institute's (SRI's) 'Trends in Antibody Dealmaking & Financing'; and SRI's "Anti-Aging Drug Discovery & Development Summit: Exploring the Molecular Basis of Aging & Commercial Prospects for Therapeutic Interventions".
David Palella is the President of BioScience Ventures Inc., a San Diego-based consulting firm founded in 1991 specializing in global strategic alliances in the biopharmaceutical, diagnostics and biotech/biomedical fields. David has extensive business expertise in the fields of therapeutic antibodies, proteomics, genomics and therapeutic strategies for aging intervention.
